vs
DIGI INTERNATIONAL INC（DGII）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
DIGI INTERNATIONAL INC的季度营收约是RIGEL PHARMACEUTICALS INC的1.8倍（$122.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 9.6%，领先374.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 17.9%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 6.6%）
Digi International Inc.是总部位于美国明尼苏达州霍普金斯的工业物联网（IIoT）科技企业，成立于1985年。上世纪90年代初，该公司以生产多线路串行数据卡闻名，可支持兼容机运行多线路公告板系统（BBS）。90年代末互联网兴起后，公司逐步转向网络接入设备与工业监测领域布局。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
DGII vs RIGL — 直观对比
营收规模更大
DGII
是对方的1.8倍
$69.8M
营收增速更快
RIGL
高出3.3%
17.9%
净利率更高
RIGL
高出374.5%
9.6%
两年增速更快
RIGL
近两年复合增速
6.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $122.5M | $69.8M |
| 净利润 | $11.7M | $268.1M |
| 毛利率 | 62.4% | 91.5% |
| 营业利润率 | 13.3% | 33.2% |
| 净利率 | 9.6% | 384.0% |
| 营收同比 | 17.9% | 21.2% |
| 净利润同比 | 16.1% | 1769.2% |
| 每股收益（稀释后） | $0.31 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DGIIRIGL
| Q4 25 | $122.5M | $69.8M | ||
| Q3 25 | $114.3M | $69.5M | ||
| Q2 25 | $107.5M | $101.7M | ||
| Q1 25 | $104.5M | $53.3M | ||
| Q4 24 | $103.9M | $57.6M | ||
| Q3 24 | $105.1M | $55.3M | ||
| Q2 24 | $105.2M | $36.8M | ||
| Q1 24 | $107.7M | $29.5M |
净利润DGIIRIGL
| Q4 25 | $11.7M | $268.1M | ||
| Q3 25 | $10.0M | $27.9M | ||
| Q2 25 | $10.2M | $59.6M | ||
| Q1 25 | $10.5M | $11.4M | ||
| Q4 24 | $10.1M | $14.3M | ||
| Q3 24 | $11.9M | $12.4M | ||
| Q2 24 | $9.7M | $-1.0M | ||
| Q1 24 | $4.0M | $-8.2M |
毛利率DGIIRIGL
| Q4 25 | 62.4% | 91.5% | ||
| Q3 25 | 63.9% | 93.2% | ||
| Q2 25 | 63.5% | 95.6% | ||
| Q1 25 | 62.1% | 91.7% | ||
| Q4 24 | 62.0% | 89.9% | ||
| Q3 24 | 61.1% | 85.5% | ||
| Q2 24 | 59.2% | 92.4% | ||
| Q1 24 | 57.9% | 93.1% |
营业利润率DGIIRIGL
| Q4 25 | 13.3% | 33.2% | ||
| Q3 25 | 12.5% | 40.9% | ||
| Q2 25 | 13.9% | 60.1% | ||
| Q1 25 | 13.1% | 23.9% | ||
| Q4 24 | 12.9% | 28.9% | ||
| Q3 24 | 14.2% | 25.4% | ||
| Q2 24 | 12.3% | 1.2% | ||
| Q1 24 | 7.6% | -23.6% |
净利率DGIIRIGL
| Q4 25 | 9.6% | 384.0% | ||
| Q3 25 | 8.7% | 40.2% | ||
| Q2 25 | 9.5% | 58.6% | ||
| Q1 25 | 10.0% | 21.5% | ||
| Q4 24 | 9.7% | 24.9% | ||
| Q3 24 | 11.3% | 22.5% | ||
| Q2 24 | 9.2% | -2.8% | ||
| Q1 24 | 3.7% | -27.9% |
每股收益（稀释后）DGIIRIGL
| Q4 25 | $0.31 | $14.11 | ||
| Q3 25 | $0.26 | $1.46 | ||
| Q2 25 | $0.27 | $3.28 | ||
| Q1 25 | $0.28 | $0.63 | ||
| Q4 24 | $0.27 | $0.82 | ||
| Q3 24 | $0.32 | $0.70 | ||
| Q2 24 | $0.26 | $-0.06 | ||
| Q1 24 | $0.11 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.9M | $155.0M |
| 总债务越低越好 | $135.0M | $52.5M |
| 股东权益账面价值 | $649.2M | $391.5M |
| 总资产 | $918.4M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.21× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资DGIIRIGL
| Q4 25 | $30.9M | $155.0M | ||
| Q3 25 | $21.9M | $137.1M | ||
| Q2 25 | $20.1M | $108.4M | ||
| Q1 25 | $26.3M | $77.1M | ||
| Q4 24 | $25.9M | $77.3M | ||
| Q3 24 | $27.5M | $61.1M | ||
| Q2 24 | $28.3M | $49.1M | ||
| Q1 24 | $23.8M | $49.5M |
总债务DGIIRIGL
| Q4 25 | $135.0M | $52.5M | ||
| Q3 25 | $159.2M | $60.0M | ||
| Q2 25 | $40.1M | $60.0M | ||
| Q1 25 | $70.0M | $60.0M | ||
| Q4 24 | $95.0M | $60.0M | ||
| Q3 24 | $123.2M | $60.0M | ||
| Q2 24 | $151.6M | $60.0M | ||
| Q1 24 | $171.8M | $60.0M |
股东权益DGIIRIGL
| Q4 25 | $649.2M | $391.5M | ||
| Q3 25 | $636.1M | $117.6M | ||
| Q2 25 | $621.5M | $81.9M | ||
| Q1 25 | $605.2M | $18.6M | ||
| Q4 24 | $590.7M | $3.3M | ||
| Q3 24 | $581.0M | $-14.6M | ||
| Q2 24 | $563.1M | $-29.9M | ||
| Q1 24 | $549.6M | $-31.7M |
总资产DGIIRIGL
| Q4 25 | $918.4M | $513.6M | ||
| Q3 25 | $922.6M | $242.5M | ||
| Q2 25 | $770.3M | $206.7M | ||
| Q1 25 | $781.0M | $176.0M | ||
| Q4 24 | $796.1M | $164.0M | ||
| Q3 24 | $815.1M | $139.4M | ||
| Q2 24 | $820.4M | $128.4M | ||
| Q1 24 | $825.3M | $126.5M |
负债/权益比DGIIRIGL
| Q4 25 | 0.21× | 0.13× | ||
| Q3 25 | 0.25× | 0.51× | ||
| Q2 25 | 0.06× | 0.73× | ||
| Q1 25 | 0.12× | 3.23× | ||
| Q4 24 | 0.16× | 18.25× | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.27× | — | ||
| Q1 24 | 0.31× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $35.2M | — |
| 自由现金流率自由现金流/营收 | 28.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | 3.04× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $111.4M | — |
8季度趋势，按日历期对齐
经营现金流DGIIRIGL
| Q4 25 | $35.6M | $22.0M | ||
| Q3 25 | $28.0M | $24.0M | ||
| Q2 25 | $24.0M | $30.5M | ||
| Q1 25 | $26.3M | $-893.0K | ||
| Q4 24 | $29.7M | $14.5M | ||
| Q3 24 | $26.4M | $21.7M | ||
| Q2 24 | $24.9M | $302.0K | ||
| Q1 24 | $13.1M | $-5.0M |
自由现金流DGIIRIGL
| Q4 25 | $35.2M | — | ||
| Q3 25 | $27.5M | — | ||
| Q2 25 | $22.9M | — | ||
| Q1 25 | $25.7M | — | ||
| Q4 24 | $29.1M | — | ||
| Q3 24 | $25.5M | — | ||
| Q2 24 | $24.5M | — | ||
| Q1 24 | $12.5M | — |
自由现金流率DGIIRIGL
| Q4 25 | 28.7% | — | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 21.3% | — | ||
| Q1 25 | 24.6% | — | ||
| Q4 24 | 28.1% | — | ||
| Q3 24 | 24.3% | — | ||
| Q2 24 | 23.2% | — | ||
| Q1 24 | 11.6% | — |
资本支出强度DGIIRIGL
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 0.5% | — |
现金转化率DGIIRIGL
| Q4 25 | 3.04× | 0.08× | ||
| Q3 25 | 2.81× | 0.86× | ||
| Q2 25 | 2.34× | 0.51× | ||
| Q1 25 | 2.50× | -0.08× | ||
| Q4 24 | 2.95× | 1.01× | ||
| Q3 24 | 2.23× | 1.75× | ||
| Q2 24 | 2.57× | — | ||
| Q1 24 | 3.27× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DGII
| Io T Productsand Services | $86.4M | 71% |
| Io T Solutions | $36.1M | 29% |
RIGL
暂无分部数据
